These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25286006)

  • 1. Differences in reaction specificity toward lipoprotein X and abnormal LDL among 6 homogeneous assays for LDL-cholesterol.
    Matsushima K; Sugiuchi H; Anraku K; Nishimura H; Manabe M; Ikeda K; Ando Y; Kondo Y; Ishitsuka Y; Irikura M; Irie T
    Clin Chim Acta; 2015 Jan; 439():29-37. PubMed ID: 25286006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum.
    Fei H; Maeda S; Kirii H; Fujigaki S; Maekawa N; Fujii H; Wada H; Saito K; Seishima M
    Clin Chem; 2000 Sep; 46(9):1351-6. PubMed ID: 10973865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X.
    Herzum I; Giehl C; Soufi M; Junclas H; Wahl HG
    Clin Chem Lab Med; 2007; 45(5):667-71. PubMed ID: 17484632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four direct homogeneous methods for the measurement of low-density lipoprotein cholesterol.
    Yamada K; Tsuji N; Fujita T; Tanaka M; Kuribayashi K; Kobayashi D; Watanabe N
    Clin Lab; 2010; 56(7-8):327-33. PubMed ID: 20857897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differences in Measured Values among Homogenous Assay Reagents of LDL-C in LP-X Positive Serum Samples].
    Abe M; Kurosawa H; Sato R; Ito K; Tomono Y; Manita D; Hirowatari Y; Yoshida H
    Rinsho Byori; 2015 Mar; 63(3):312-8. PubMed ID: 26524853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-X fifty years after its original discovery.
    Fellin R; Manzato E
    Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):4-8. PubMed ID: 30503707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pitfalls in homogeneous assays for HDL-c and LDL-c in serum].
    Sugiuchi H; Manabe M; Irie T; Nagata S; Ando Y; Okabe H
    Rinsho Byori; 2005 Feb; 53(2):138-43. PubMed ID: 15796047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved specificity of a new homogeneous assay for LDL-cholesterol in serum with abnormal lipoproteins.
    Iwasaki Y; Matsuyama H; Nakashima N
    Clin Chem; 2006 May; 52(5):886-8. PubMed ID: 16556687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of lipoprotein-X accumulation in severe cholestasis by semi-selective LDL-apheresis.
    Franceschini G; Busnach G; Chiesa G; Sirtori CR
    Am J Med; 1991 May; 90(5):633-8. PubMed ID: 2029022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry and clinical relevance of lipoprotein X.
    Narayanan S
    Ann Clin Lab Sci; 1984; 14(5):371-4. PubMed ID: 6476782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The X of dyslipemias].
    Merino Viveros M; Vega Piñero B; Gil Ares F; Guijarro de Armas MG; Montaño Martinez JM; Navea Aguilera C
    Nutr Hosp; 2014 Apr; 29(4):953-5. PubMed ID: 24679041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of the HDL-C and LDL-C direct methods and the subsequent evolution].
    Sugiuchi H; Matsushima K; Akiyoshi Y; Maeda K; Ando Y
    Rinsho Byori; 2012 Jul; 60(7):632-6. PubMed ID: 22973722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential reactivities of four homogeneous assays for LDL-cholesterol in serum to intermediate-density lipoproteins and small dense LDL: comparisons with the Friedewald equation.
    Yamashita S; Kawase R; Nakaoka H; Nakatani K; Inagaki M; Yuasa-Kawase M; Tsubakio-Yamamoto K; Sandoval JC; Masuda D; Ohama T; Nakagawa-Toyama Y; Matsuyama A; Nishida M; Ishigami M
    Clin Chim Acta; 2009 Dec; 410(1-2):31-8. PubMed ID: 19751710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversy over the atherogenicity of lipoprotein-X.
    Miida T; Hirayama S
    Curr Opin Endocrinol Diabetes Obes; 2019 Apr; 26(2):117-123. PubMed ID: 30694826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter evaluation of four homogenous LDL-cholesterol assays].
    Bayer P; Veinberg F; Couderc R; Cherfils C; Cambillau M; Cosson C; Fradin S; Gillery P; Steinmetz J; Legrand A; Egloff M; Beucler I
    Ann Biol Clin (Paris); 2005; 63(1):27-41. PubMed ID: 15689310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.
    Walli AK; Seidel D
    J Clin Invest; 1984 Sep; 74(3):867-79. PubMed ID: 6470142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-X fails to inhibit hydroxymethylglutaryl coenzyme A reductase in HepG2 cells.
    Edwards CM; Otal MP; Stacpoole PW
    Metabolism; 1993 Jul; 42(7):807-13. PubMed ID: 8345791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate.
    Griffin E; Breckenridge WC; Kuksis A; Bryan MH; Angel A
    J Clin Invest; 1979 Dec; 64(6):1703-12. PubMed ID: 227938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-X.
    Narayanan S
    CRC Crit Rev Clin Lab Sci; 1979 Aug; 11(1):31-51. PubMed ID: 389551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.